Major Growth Driver Identified in 2025 Clinical Diagnostics Market: Rising Chronic Disease Incidence Driving Growth In The Clinical Diagnostics Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Clinical Diagnostics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Recent years have witnessed substantial growth in the clinical diagnostics market size. The market is projected to expand from $76.27 billion in 2024 to $81.91 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The historic period's growth is primarily driven by factors such as a surge in chronic diseases, increased usage of point-of-care diagnostic products, a rising number of tests triggered by a continuous increase in patients, and government funding. Additionally, the growing demand for personalized medicine and a booming geriatric population also contribute to this expansion.

Clinical Diagnostics Market Size Forecast: What's the Projected Valuation by 2029?
Anticipated robust expansion in the clinical diagnostics market is projected in the forthcoming years. The market is predicted to develop to $108.58 billion by 2029, with a compound annual growth rate (CAGR) of 7.3%. This surge during the projection period is primarily due to the rising need for early disease identification, burgeoning healthcare infrastructure, escalating research and development investments, augmented demand for molecular diagnostics, and increasing occurrence of diseases tied to lifestyle. Key trends expected during this period consist of technological progression, digital pathology, artificial intelligence, wearable healthcare devices, and telemedicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

What Are the Drivers Transforming the Clinical Diagnostics Market?
The surge of chronic diseases is anticipated to boost the growth of the clinical diagnostics market in the future. Chronic illnesses are persisting health conditions that typically can be managed, but not cured. They often require continuous medical care and can hinder daily life activities. Factors like unhealthy lifestyles, socioeconomic differences, and aging populations primarily trigger the increasing occurrence of chronic diseases. These factors intensify the risk of conditions such as cardiac diseases, diabetes, and cancer. Clinical diagnostics plays a pivotal role in accurate diagnosis, disease progression monitoring, treatment management, early detection of complications, personalized medicine, risk factor assessment, and fostering patient education and self-management concerning chronic diseases. For example, the United States a-based medicine library, National Center for Biotechnology Information (NCBI), projected in January 2023 that the count of individuals aged 50 and over suffering from one or more chronic diseases is set to rise by 99.5% by 2050, from a 72.52 million in 2020 to 142.66 million. Thus, the escalating incidence of chronic diseases fuels the clinical diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18537&type=smp

What Long-Term Trends Will Define the Future of the Clinical Diagnostics Market?
Major operators in the clinical diagnostics industry are concentrating on the invention of novel applications such as advanced liquid biopsy tests, which facilitate comprehensive genomic profiling of solid tumors. Liquid biopsy assays are non-intrusive tests that examine blood samples to find cancer-connected biomarkers such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA). These tests yield valuable insights for diagnosis, treatment monitoring, and tailored medicine. For instance, in November 2023, a biotech firm based in the United States, Illumina Inc., introduced TruSight Oncology 500 ctDNA v2, an innovative liquid biopsy assay for comprehensive genomic profiling of solid tumors. This groundbreaking assay can identify genetic changes and variations in tumors with high accuracy, offering a thorough examination of the tumor's molecular composition. The assay improves the ability to track tumor changes and modify treatment approaches, thereby enhancing personalized treatment strategies. The assay promises to deliver quick and trustworthy outcomes, enabling prompt clinical decisions and progress in the field of cancer diagnostics.

Which Segments in the Clinical Diagnostics Market Offer the Most Profit Potential?
The clinical diagnostics market covered in this report is segmented -

1) By Test: Lab Test, Imaging Test, Other Tests
2) By Product: Instruments, Reagents, Other Products
3) By End User: Hospital Laboratory, Diagnostic Laboratory, Point-Of-Care Testing, Other End Users

Subsegments
1) By Lab Test: Blood Tests, Urine Tests, Genetic Tests, Biopsy And Cytology Tests
2) By Imaging Test: X-Ray, Mri (Magnetic Resonance Imaging), Ct Scan (Computed Tomography), Ultrasound, Pet Scan (Positron Emission Tomography)
3) By Other Tests: Molecular Diagnostics, Point-Of-Care Tests, Pregnancy Tests, Allergy Tests

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18537&type=smp

Which Firms Dominate the Clinical Diagnostics Market by Market Share and Revenue in 2025?
Major companies operating in the clinical diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, FUJIFILM Corporation, Becton, inson and Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S.A., Sonic Healthcare Limited, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Ortho Clinical Diagnostics, BioReference Laboratories Inc., NeoGenomics Laboratories Inc.

Which Regions Offer the Highest Growth Potential in the Clinical Diagnostics Market?
North America was the largest region in the clinical diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18537

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.